Definitive Treatment Of Primary Spontaneous Pneumothorax A 10 Year Experience
Eva Brysch1, João Gonçalves2, Ricardo Ferreira3
1Departamento do Tórax, Centro Hospitalar Universitário Lisboa Norte, Portugal.
Summary
Video-assisted thoracic surgery (VATS) is more effective than medical pleurodesis (MP) for treating primary spontaneous pneumothorax (PSP), significantly reducing recurrence rates. VATS is recommended as the preferred first-line treatment for PSP patients.
Area of Science:
- Thoracic surgery
- Pulmonology
- Medical research
Background:
- Primary spontaneous pneumothorax (PSP) lacks underlying lung disease.
- Recurrent or persistent PSP requires definitive treatment.
- Comparing medical pleurodesis (MP) and video-assisted thoracic surgery (VATS) for PSP is crucial.
Purpose of the Study:
- To compare the effectiveness of MP versus VATS for definitive PSP treatment.
- To evaluate recurrence rates and complications associated with each method.
Main Methods:
- Retrospective study of 133 PSP patients over 10 years.
- Comparison of baseline characteristics, perioperative data, and follow-up outcomes.
- Patients underwent either MP or VATS.
Main Results:
- Both MP and VATS showed similar hospital stays and low complication rates.
- VATS group had a longer chest tube duration (3.56 days vs 2.94 days).
- MP group had a significantly higher PSP recurrence rate (11.1% vs 1.3% for VATS).
Conclusions:
- VATS demonstrates a significantly lower recurrence rate compared to MP for PSP.
- Both MP and VATS are safe with short hospital stays and few complications.
- VATS should be considered the first-line treatment for PSP.
Related Concept Videos
01:27Pneumothorax-II
711
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
711
01:26Flail Chest-II
420
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
420
01:26Pneumothorax-I
925
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
925
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
157
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
157
01:29Acute Respiratory Failure-V
341
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
341
01:28Pneumonia IV: Management
643
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
643